Trials / Completed
CompletedNCT00804102
Transcorneal Electrical Stimulation Therapy for Retinal Disease
Transcorneal Electrical Stimulation Therapy for Retinal Disease - A Randomized, Single-blind Pilot Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Okuvision GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Transcorneal stimulation may enable neurons to survive degeneration processes via enhanced secretion of neurotrophic substances and direct stimulation of neurons.
Conditions
- Retinitis Pigmentosa
- Macula Off
- Primary Open Angle Glaucoma
- Hereditary Macular Degeneration
- Treated Retina Detachment
- Retinal Artery Occlusion
- Retinal Vein Occlusion
- Non-Arthritic-Anterior-Ischemic Optic-Neuropathy
- Hereditary Autosomal Dominant Optic Atrophy
- Dry Age Related Macular Degeneration
- Ischemic Macula Edema
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Transcorneal Electrical Stimulation | Neurostimulator drives Dawson-Trick-Litzkow electrode attached to patient eye. Different modi are used to stimulate patients. |
| DEVICE | DTL-electrode attached without energy | DTL-electrode attached to patient eye receives no energy from neurostimulator. Treatment times remain the same as used for each treatment arm. |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2008-12-08
- Last updated
- 2012-05-04
Source: ClinicalTrials.gov record NCT00804102. Inclusion in this directory is not an endorsement.